Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Belite Bio, Inc BLTE

Set alert

Price alert · BLTE

All alert types
154.51 USD +0.84 +0.55%

As of Nov 3, 12:31 PM ET

Bid
153.59 × 1
Ask
154.57 × 1
153.41 Day range 157.47
102.00 52-week range 200.00
YTD
-3.41%
1 year
+37.46%
Open
156.01
Prev close
153.67
Mkt cap
6.20B
Vol
93.80K
Avg vol
177.40K
EPS
-2.74
P/E
0.00
Div yield
0.00%
More statistics
Low
153.41
High
157.47
Forward P/E
68.00
Beta
-1.19
Short ratio
7.77
Inst. own
24.27%
Dividend
0.00
Ex-div date
Earnings
Nov 9, 2026
50-d avg
161.47
200-d avg
160.36
1y target
227.44

1D chart

Chart tools
Interval
1m5m15m30m

Signals (18)
NameTimeAgo
RSI: Oversold11:36 AM56 minutes ago
SMA: Bearish11:28 AM1 hour ago
SMA: Bearish11:28 AM1 hour ago
MACD: Sell Signal11:25 AM1 hour ago
RSI: Overbought11:14 AM1 hour ago
SMA: Bullish11:13 AM1 hour ago
SMA: Bullish11:10 AM1 hour ago
MACD: Buy Signal11:08 AM1 hour ago
RSI: Oversold10:58 AM1 hour ago
SMA: Bearish10:45 AM1 hour ago
SMA: Bearish10:45 AM1 hour ago
MACD: Sell Signal10:45 AM1 hour ago
RSI: Oversold10:45 AM1 hour ago
SMA: Bearish10:28 AM2 hours ago
SMA: Bullish10:21 AM2 hours ago
MACD: Buy Signal10:14 AM2 hours ago
RSI: Oversold10:10 AM2 hours ago
RSI: Oversold9:59 AM2 hours ago

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 227.44 +47.2% upside
Target (low)
185.00
Target (mean)
227.44
Target (high)
303.00
Ratings (0m) 9 9 buy · 0 hold · 0 sell
  • Strong buy2
  • Buy7
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 9
  • 1 month ago 9
  • 2 months ago 8

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

BLTE analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.76875-1.16 – -0.52-0.65-18.3%00.0%8
Next quarter-0.90375-1.43 – -0.51-0.70-29.1%00.0%8
Current year-2.94-3.97 – -1.30-2.31-27.1%00.0%8
Next year2.26-2.87 – 15.37-2.94+177.0%274.23M0.0%8

Upgrades and downgrades

The latest rating changes

BLTE analyst upgrades and downgrades
DateFirmActionFromTo
Oct 15, 2026HC Wainwright & Co.ReiteratedBuyBuy
Sep 9, 2026MizuhoMaintainedOutperformOutperform
Sep 8, 2026HC Wainwright & Co.MaintainedBuyBuy
Sep 4, 2026Canaccord GenuityInitiated—Buy
Aug 14, 2026Morgan StanleyMaintainedOverweightOverweight
Aug 14, 2026Cantor FitzgeraldMaintainedOverweightOverweight
Aug 12, 2026HC Wainwright & Co.MaintainedBuyBuy
Jun 15, 2026HC Wainwright & Co.ReiteratedBuyBuy
May 26, 2026MizuhoMaintainedOutperformOutperform
May 21, 2026HC Wainwright & Co.ReiteratedBuyBuy
Apr 22, 2026HC Wainwright & Co.ReiteratedBuyBuy
Apr 13, 2026HC Wainwright & Co.ReiteratedBuyBuy
Mar 3, 2026HC Wainwright & Co.MaintainedBuyBuy
Mar 3, 2026Morgan StanleyMaintainedOverweightOverweight
Mar 3, 2026Cantor FitzgeraldMaintainedOverweightOverweight
Jan 28, 2026HC Wainwright & Co.ReiteratedBuyBuy
Jan 26, 2026B of A SecuritiesInitiated—Buy
Jan 6, 2026Morgan StanleyInitiated—Overweight
Dec 2, 2025MizuhoUpgradeNeutralOutperform
Dec 1, 2025HC Wainwright & Co.MaintainedBuyBuy
Nov 20, 2025MizuhoInitiated—Neutral
Oct 31, 2025BenchmarkMaintainedBuyBuy
Sep 15, 2025HC Wainwright & Co.MaintainedBuyBuy
Jul 3, 2025HC Wainwright & Co.ReiteratedBuyBuy
May 15, 2025Cantor FitzgeraldReiteratedOverweightOverweight
May 15, 2025HC Wainwright & Co.ReiteratedBuyBuy
Mar 26, 2025BenchmarkReiteratedBuyBuy
Mar 18, 2025Cantor FitzgeraldReiteratedOverweightOverweight
Mar 18, 2025HC Wainwright & Co.ReiteratedBuyBuy
Jan 21, 2025BenchmarkMaintainedBuyBuy